Procter & Gamble Health Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
PGHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Procter & Gamble Health Limited has filed its financial results for the quarter and nine months ended December 31, 2025 with the stock exchange. The filing is a standard regulatory disclosure under listing requirements and signals the release of the company's Q3 FY26 and YTD earnings. The actual detailed numbers, segment performance, and auditor remarks are contained in the results document itself, which is not included in this notification. Investors should refer to the full results PDF for revenue, profit, margin, and cash flow figures.
This is a routine compliance filing and is not a material event on its own; the actual market reaction will depend on the numbers reported in the detailed results, which are typically announced separately. Watch for revenue growth, margin trends, and any guidance changes in the full results.